Medical Devices
-
Medtronic completes SPR Therapeutics acquisition
Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.
By Nick Paul Taylor • July 17, 2026 -
Intuitive ties Q2 procedure softness to ACA subsidy expirations
Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.
By Susan Kelly • July 17, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
DePuy Synthes adds spine implants with Expanding Innovations buy
DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys portfolio.
By Elise Reuter • July 16, 2026 -
Abbott reports diagnostics growth since $21B Exact Sciences buy
The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.
By Elise Reuter • July 16, 2026 -
Zimmer Biomet names new Asia Pacific president
Chintan Desai, formerly of Alcon and GE HealthCare, has experience leading medtech teams in the region.
By Nick Paul Taylor • July 16, 2026 -
Vicarious Surgical board proposes dissolving the company
The robot developer’s board set a July 21 date for shareholders to vote on a proposal to wind down operations amid expectations for continued operating losses.
By Susan Kelly • July 15, 2026 -
SS Innovations names Sarah Romano as CFO
Romano, who is joining from rival robotic surgery company Vicarious Surgical, will step into a position that has been held by a series of executives over the past year.
By Nick Paul Taylor • July 15, 2026 -
Medtronic recalls heart valve delivery catheter for risk of tip detaching
Certain delivery systems that are used to insert a pulmonary valve have an increased risk of distal tip detachment, the company said. The valve itself is not affected by the recall.
By Elise Reuter • July 14, 2026 -
HistoSonics wins Europe’s CE mark for histotripsy system
HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.
By Nick Paul Taylor • July 14, 2026 -
Edwards will pay $10M to settle FTC charges of skirting antitrust review
The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.
By Susan Kelly • July 13, 2026 -
Sponsored by Veeva MedTech
Expert insights to transform your evidence generation strategy
Modernize evidence generation with unified strategies and AI to accelerate time to market.
July 13, 2026 -
Illumina builds out C-suite with 2 new execs
The gene sequencing company this week named a new chief commercial officer and chief legal officer.
By Elise Reuter • July 10, 2026 -
Medicaroid wins Europe’s CE mark for Hinotori surgical robot
The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.
By Susan Kelly • July 10, 2026 -
Stereotaxis closes Robocath takeover
With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.
By Susan Kelly • July 9, 2026 -
4 takeaways from MDUFA VI draft agreement
The draft agreement outlines the Food and Drug Administration’s goals for medical device reviews from 2028 to 2032.
By Elise Reuter • July 9, 2026 -
J&J wins FDA approval for dual-energy ablation catheter
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
By Nick Paul Taylor • July 9, 2026 -
Resmed to sell MatrixCare for $490M to private equity firm
Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.
By Susan Kelly • July 8, 2026 -
Top surgical robotics stories in the first half of 2026
The market for robotic surgery got more competitive this year, with Medtronic, Stryker, CMR Surgical and Distalmotion introducing new platforms. Check up on their progress and more in MedTech Dive’s roundup of robotics coverage.
By Susan Kelly • July 8, 2026 -
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
By Nick Paul Taylor • July 7, 2026 -
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
By Nick Paul Taylor • July 6, 2026 -
Medicare slashes 340B payments, broadens site-neutral policies in proposed 2027 payment rule
The rule, released Thursday, builds on Trump administration priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
By Sydney Halleman • July 6, 2026 -
US blocks quick USMCA extension, putting annual review process into motion
The U.S., Mexico and Canada will continue negotiating about potential adjustments to the trilateral free trade agreement, which will remain in place until at least 2036.
By Phil Neuffer • July 2, 2026 -
Retrieved from Hologic on January 16, 2025
FDA updates Hologic BioZorb recall, citing 252 injuries
While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.
By Susan Kelly • July 1, 2026 -
FDA authorizes more devices so far in 2026, but it’s taking longer
Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.
By Elise Reuter • July 1, 2026 -
Roche takes on Illumina with new NGS system
When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.”
By Susan Kelly • June 30, 2026